- CooperSurgical revenues were $342 million, up 4.5% reported and 2% organic, with fertility up 6% and office/surgical up 3%.
- CooperVision revenues were $718 million, up 6.3% reported and 2.4% organic, with softness in Clarity and e-commerce in Asia Pac.
- Free cash flow was strong at $165 million with CapEx of $97 million, and net debt declined to $2.35 billion.
- Gross margin improved by 70 basis points to 67.3%, supported by efficiency gains, mix, and positive foreign exchange.
- Non-GAAP earnings grew 15% year-over-year to $1.10 per share, driven by margin improvements and operational efficiency.
- Operating income rose 8% with operating margin expanding to 26.1%, reflecting disciplined cost management.
- Q3 consolidated revenues increased 5.7% year-over-year to $1.06 billion, with 2% organic growth.
Related items and other data are not available for this feed item.
Dafinchi